Ascentage Pharma Group International (HKG:6855)
Hong Kong
· Delayed Price · Currency is HKD 45.95
+0.80 (1.77%)
May 13, 2025, 3:45 PM HKT
Ascentage Pharma Group International Employees
Ascentage Pharma Group International had 567 employees as of December 31, 2024. The number of employees decreased by 16 or -2.74% compared to the previous year.
Employees
567
Change (1Y)
-16
Growth (1Y)
-2.74%
Revenue / Employee
1.84M HKD
Profits / Employee
-760.94K HKD
Market Cap
15.47B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BeiGene | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| JD Health International | 3,564 |
| WuXi Biologics | 12,575 |
| Alibaba Health Information Technology | 1,435 |
| Innovent Biologics | 5,659 |
| Akeso | 3,035 |
| Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
Ascentage Pharma Group International News
- 6 weeks ago - Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan - Benzinga
- 6 weeks ago - Earnings Scheduled For March 27, 2025 - Benzinga
- 6 weeks ago - Ascentage Pharma Group International (AAPG) Showcases Innovative Cancer Therapies at AACR 2025 - GuruFocus
- 3 months ago - Takeda-backed Ascentage Pharma aims to raise $126 mln in US IPO - Reuters
- 3 months ago - Ascentage Pharma Announces Pricing of U.S. Initial Public Offering - GlobeNewsWire
- 3 months ago - Takeda-backed Ascentage Pharma targets $1.75 billion valuation in US IPO - Reuters
- 4 months ago - Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 5 months ago - Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months - PRNewsWire